MAMarissa M. Alejandria

Marissa M. Alejandria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marissa M. Alejandria has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enabling research for therapeutics

    by Xin Hui Sam, Marissa Alejandria, John Amuasi, Barnaby Young

    Research is a vital part of the effective response to a disease outbreak. Given the wide spectrum of potential outbreaks and the varying therapeutic research questions, it is challenging to develop a generic, broadly applicable clinical trial protocol as part of outbreak research preparedness. However, when considering approaches, there are common threads which can be pulled together and examples of best practice which have facilitated an effective outbreak response via research in the past. These can be replicated or adapted. This chapter will consider these common themes and discuss relevant examples that can facilitate timely, relevant, and clinically meaningful research on therapeutics during an outbreak.

  • Open Access

    Bacterial coinfection and antimicrobial use among patients with COVID-19 infection in a referral center in the Philippines: A retrospective cohort study

    by Cybele L. Abad, Joanne Carmela M. Sandejas, Jonnel B. Poblete, Anna Flor G. Malundo, Maria Sonia S. Salamat, Marissa M. Alejandria


  • Open Access

    High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey

    by Mary Ann D. Lansang, Marissa M. Alejandria, Irwin Law, Noel R. Juban, Maria Lourdes E. Amarillo, Olivia T. Sison, Jose Rene B. Cruz, Concepcion F. Ang, Joseph Adrian L. Buensalido, Johanna Patricia A. Cañal, et al.

    Setting: The 3rd national tuberculosis (TB) survey in the Philippines in 2007 reported a significant decline in the prevalence of TB. Since then, more significant investments for TB control have been made, yet TB burden estimates from routine surveillance data remain relatively stable. Objective: To estimate the prevalence of bacteriologically confirmed pulmonary TB in the Philippines amongst individuals aged ≥15 years in 2016. Design: In March–December 2016, we conducted a population-based survey with stratified, multi-stage cluster sampling of residents in 106 clusters aged ≥15 years. Survey participants were screened for TB by symptom-based interview and digital chest X-ray. Those with cough ≥2 weeks and/or haemoptysis and/or chest X-ray suggestive of TB were requested to submit 2 sputum specimens for Xpert MTB/RIF, direct sputum smear microscopy using LED fluorescent microscopy, and mycobacterial solid culture (Ogawa method). Bacteriologically confirmed pulmonary TB was defined as MTB culture positive and/or Xpert positive. Results: There were 46,689 individuals interviewed, and 41,444 (88.8%) consented to a chest X-ray. There were 18,597 (39.8%) eligible for sputum examination and 16,242 (87.3%) submitted at least one specimen. Out of 16,058 sputum-eligible participants, 183 (1.1%) were smear-positive. There were 466 bacteriologically confirmed TB cases: 238 (51.1%) Xpert positive, 69 (14.8%) culture positive, and 159 (34.1%) positive by both Xpert and culture. The estimated TB prevalence per 100,000 population aged ≥15 years was 434 (95% CI: 350−518) for smear-positive TB, and 1,159 (95% CI: 1,016−1,301) for bacteriologically confirmed TB. Conclusion: This nationally representative survey found that the TB burden in the Philippines in 2016 was higher than estimated from routine TB surveillance data. There was no evidence of a decline in smear and culture positive TB from the 2007 survey despite significant investments in TB control. New strategies for case-finding and patient-centered care must be intensified and expanded.


  • Assessing the cost-effectiveness of a Universal Rotavirus Vaccination program for the Philippines using a dynamic transmission model

    by H.Y. Lam, D.B. Wu, A.S. Rivera, M.M. Alejandria, G.N. Velasco, O.T. Sison, M.A. Ladia, J.B. Mantaring, M. Santillan